Non-invasive cancer detection: Strategies for the identification of novel cancer markers

IUBMB Life

Volumn 58, Issue 4, 2006, Pages 193-198

  Sorio, Claudio ^a   Mauri, Pierluigi ^b   Pederzoli, Paolo ^a   Scarpa, Aldo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

Biological markers; Cancer detection

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

CANCER DIAGNOSIS; EARLY DIAGNOSIS; GENOMICS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; TANDEM MASS SPECTROMETRY;

ALPHA-FETOPROTEINS; ANIMALS; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FALSE POSITIVE REACTIONS; HUMANS; MALE; MICE; NEOPLASMS; PROSTATE-SPECIFIC ANTIGEN; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745112932     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540600719598     Document Type: Review

References (40)

1. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89-95.
2. Pritzker, K. P. (2002) Cancer biomarkers: easier said than done. Clin. Chem. 48, 1147-1150.
3. Stenman, U. H., Leinonen, J., Zhang, W. M., and Finne, P. (1999) Prostate-specific antigen. Semin. Cancer Biol. 9, 83-93.
4. Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Klapdor, R., Lamerz, R., Nilsson, O., Sturgeon, C., and Topolcan, O. (2003) Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur. J. Cancer 39, 718-727.
5. Abelev, G. I., and Eraiser, T. L. (1999) Cellular aspects of alpha-fetoprotein reexpression in tumors. Semin. Cancer Biol. 9, 95-107.
6. Ni, X. G., Bai, X. F., Mao, Y. L., Shao, Y. F., Wu, J. X., Shan, Y., Wang, C. F., Wang, J., Tian, Y. T., Liu, Q., Xu, D. K., and Zhao, P. (2005) The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur. J. Surg. Oncol. 31, 164-169.
7. Ransohoff, D. F. (2004) Rules of evidence for cancer molecular-marker discovery and validation. Nat. Rev. Cancer 4, 309-314.
8. Clark, H. F., Gurney, A. L., Abaya, E., Baker, K., Baldwin, D., Brush, J., Chen, J., Chow, B., Chui, C., Crowley, C., Currell, B., Deuel, B., Dowd, P., Eaton, D., Foster, J., Grimaldi, C., Gu, Q., Hass, P. E., Heldens, S., Huang, A., Kim, H. S., Klimowski, L., Jin, Y., Johnson, S., Lee, J., Lewis, L., Liao, D., Mark, M., Robbie, E., Sanchez, C., Schoenfeld, J., Seshagiri, S., Simmons, L., Singh, J., Smith, V., Stinson, J., Vagts, A., Vandlen, R., Watanabe, C., Wieand, D., Woods, K., Xie, M. H., Yansura, D., Yi, S., Yu, G., Yuan, J., Zhang, M., Zhang, Z., Goddard, A., Wood, W. I., Godowski, P., and Gray, A. (2003) The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 13, 2265-2270.
9. Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., Sutherland, R. L., Breit, S. N., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. (2003) Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. USA 100, 3410-3415.
10. Smirnov, D. A., Zweitzig, D. R., Foulk, B. W., Miller, M. C., Doyle, G. V., Pienta, K. J., Meropol, N. J., Weiner, L. M., Cohen, S. J., Moreno, J. G., Connelly, M. C., Terstappen, L. W., and O'Hara, S. M. (2005) Global gene expression profiling of circulating tumor cells. Cancer Res. 65, 4993-4997.
11. Washburn, M. P., Wolters, D., and Yates, J. R., 3rd. (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247.
12. Link, A. J., Eng, J., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., and Yates, J. R., 3rd. (1999) Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 17, 676-682.
13. Anderson, L., and Seilhamer, J. (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533-537.
14. Gygi, S. P., Rochon, Y., Franza, B. R., and Aebersold, R. (1999) Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 19, 1720-1730.
15. Gronborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., Maitra, A., and Pandey, A. (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics 5, 157-171.
16. Vukmirovic, O. G., and Tilghman, S. M. (2000) Exploring genome space. Nature 405, 820-822.
17. Eisenberg, D., Marcotte, E. M., Xenarios, I., and Yeates, T. O. (2000) Protein function in the post-genomic era. Nature 405, 823-826.
18. Roboz, J. (2005) Mass spectrometry in diagnostic oncoproteomics. Cancer Invest. 23, 465-478.
19. Jenkins, R. E., and Pennington, S. R. (2001) Arrays for protein expression profiling: towards a viable alternative to two-dimensional gel electrophoresis? Proteomics 1, 13-29.
20. Fung, E. T., Thulasiraman, V., Weinberger, S. R., and Dalmasso, E. A. (2001) Protein biochips for differential profiling. Curr. Opin. Biotechnol. 12, 65-69.
21. Seibert, V., Wiesner, A., Buschmann, T., and Meuer, J. (2004) Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research. Pathol. Res. Pract. 200, 83-94.
22. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., and Liotta, L. A. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572-577.
23. Editorial (2004) Proteomic diagnostics tested. Nature 429, 487.
24. Diamandis, E. P. (2004) OvaCheck: doubts voiced soon after publication. Nature 430, 611.
25. Sorace, J. M., and Zhan, M. (2003) A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics 4, 24.
26. Baggerly, K. A., Morris, J. S., and Coombes, K. R. (2004) Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20, 777-785.
27. Rai, A. J., Zhang, Z., Rosenzweig, J., Shih Ie, M., Pham, T., Fung, E. T., Sokoll, L. J., and Chan, D. W. (2002) Proteomic approaches to tumor marker discovery. Arch. Pathol. Lab. Med. 126, 1518-1526.
28. Shiwa, M., Nishimura, Y., Wakatabe, R., Fukawa, A., Arikuni, H., Ota, H., Kato, Y., and Yamori, T. (2003) Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochem. Biophys. Res. Commun. 309, 18-25.
29. Ye, B., Cramer, D. W., Skates, S. J., Gygi, S. P., Pratomo, V., Fu, L., Horick, N. K., Licklider, L. J., Schorge, J. O., Berkowitz, R. S., and Mok, S. C. (2003) Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin. Cancer Res. 9, 2904-2911.
30. Thulasiraman, V., McCutchen-Maloney, S. L., Motin, V. L., and Garcia, E. (2001) Detection and identification of virulence factors in Yersinia pestis using SELDI ProteinChip system. Biotechniques 30, 428-432.
31. Uchida, T., Fukawa, A., Uchida, M., Fujita, K., and Saito, K. (2002) Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. J. Proteome Res. 1, 495-499.
32. Wolters, D. A., Washburn, M. P., and Yates, J. R., 3rd. (2001) An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73, 5683-5690.
33. Yi, E. C., Li, X. J., Cooke, K., Lee, H., Raught, B., Page, A., Aneliunas, V., Hieter, P., Goodlett, D. R., and Aebersold, R. (2005) Increased quantitative proteome coverage with (13)C/(12)C-based, acid-cleavable isotope-coded affinity tag reagent and modified data acquisition scheme. Proteomics 5, 380-387.
34. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999.
35. Mauri, P., Scarpa, A., Nascimbeni, A. C., Benazzi, L., Parmagnani, E., Mafficini, A., Della Peruta, M., Bassi, C., Miyazaki, K., and Sorio, C. (2005) Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. Faseb J. 19, 1125-1127.
36. Regonesi, M. E., Del Favero, M., Basilico, F., Briani, F., Benazzi, L., Tortora, P., Mauri, P., and Deho, G. (2006) Analysis of the Escherichia coli RNA degradosome composition by a proteomic approach. Biochimie 88, 151-161.
37. Liu, H., Sadygov, R. G., and Yates, J. R., 3rd. (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201.
38. Gao, J., Opiteck, G. J., Friedrichs, M. S., Dongre, A. R., and Hefta, S. A. (2003) Changes in the protein expression of yeast as a function of carbon source. J. Proteome Res. 2, 643-649.
39. Sorio, C., Bonora, A., Orlandini, S., Moore, P. S., Capelli, P., Cristofori, P., Dal Negro, G., Marchiori, P., Gaviraghi, G., Falconi, M., Pederzoli, P., Zamboni, G., and Scarpa, A. (2001) Successful xenografting of cryopreserved primary pancreatic cancers. Virchows Arch 438, 154-158.
40. Kellner, U., Steinert, R., Seibert, V., Heim, S., Kellner, A., Schulz, H. U., Roessner, A., Kruger, S., and Reymond, M. (2004) Epithelial cell preparation for proteomic and transcriptomic analysis in human pancreatic tissue. Pathol. Res. Pract. 200, 155-163.